Also listed on Albireo Pharma, Inc., an earlier holder on the record. The recorded assignments below show how it moved.
Term ends Apr 6, 2027 · Medium confidence
20-year base term ended Sep 29, 2026
Sep 29, 2006
Apr 6, 2027
Dec 27, 2011
This patent's term runs 189 days past its 20-year base term on prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. All three maintenance fees are recorded paid; no more fees are due. Confidence: Medium. from the record
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Sep 29, 2006, when application 11/537,335, the earliest non-provisional in its chain, was filed (this one was filed Nov 26, 2008); a parent in its chain could not be resolved (the next row) | Sep 29, 2026 | High confidence |
| Continuity chain | A parent in the chain could not be resolved | dated from this application's own claim | Medium confidence |
| Patent term adjustment | +189 days, USPTO patent term adjustment record | Apr 6, 2027 | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 7,713,929, US 7,718,609) | resolves to Apr 6, 2027, no earlier than this term, so no change | Medium confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 3 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Apr 6, 2027 | Medium confidence |
This family
| US 7,713,929 | Lapsed on the fee record May 2022 | May 2022 |
| US 7,718,609 | In force no later than Aug 2027 | no later than Aug 2027 |
| US 8,084,420 | this patent Apr 2027 | Apr 2027 |
Assignments
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Feb 11, 2009 Reel 22242, frame 532 | Steiner, Solomon S.; Pohl, Roderike | Biodel Inc. | Assignment of Assignor's Interest |
| Nov 18, 2016 Reel 40651, frame 811 | Biodel Inc. | Albireo Pharma, Inc. | Change of Name |
| May 16, 2018 Reel 46186, frame 386 | Albireo Pharma, Inc. | Eli Lilly and Company | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
A terminal disclaimer resolved from the filed document, referencing US 7,713,929, US 7,718,609, ends no earlier than this term, so it caps nothing.